Jonathan R Day, MD, PharmD¹, Melissa C. Larson, MS^2*, Carla Casulo, MD³, Yucai Wang, MD, PhD⁴, Dai Chihara, MD, PhD⁵, Brad S. Kahl, MD⁶, Peter Martin, FRCPC, MD, MS⁷, Izidore S. Lossos, MD⁸, Victor M. Orellana-Noia, MD⁹, Richard Burack, MD, PhD¹⁰, Jonathan W. Friedberg, MD, MMSc¹¹, Thomas M. Habermann, MD⁴, James R. Cerhan, MD, PhD², Christopher R. Flowers, MD¹², Matthew J. Maurer, MS, DMSc^13* and Brian K. Link, MD¹⁴

¹Department of Internal Medicine, University of Iowa Carver College of Medicine, North Liberty, IA
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³University of Rochester Medical Center, Rochester, NY
⁴Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁵Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston
⁶Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
⁷Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
⁸Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
⁹Winship Cancer Institute, Emory University, Atlanta, GA
¹⁰Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY
¹¹James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
¹²Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
¹⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA

Frédéric Boissard, PharmD, PhD^1*, Hervé Tilly, MD, PhD², Georg Lenz, MD, Prof.³, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil⁴, Antonio Pinto, MD^5*, Laurie H. Sehn, MD, MPH⁶, Gilles Salles, MD, PhD⁷, Mathilde Roussel, MSc^1*, Leonardo Simonella, PhD^1*, Rodrigo Ho, PharmB^1*, Jamie Hirata, PharmD⁸, Calvin Lee, MD⁸, Anthony Masaquel, PhD, MPH^8* and Aino Launonen, MSc^1*

¹F. Hoffmann-La Roche Ltd, Basel, Switzerland
²Department of Hematology and U1245, Centre Henri Becquerel and University of Rouen, Rouen, France
³University Hospital Münster, Münster, Germany
⁴Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁵National Cancer Institute, Fondazione G. Pascale, IRCCS, Naples, Italy
⁶Centre for Lymphoid Cancer at BC Cancer and the University of British Columbia, Vancouver, Canada
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸Genentech, Inc., South San Francisco, CA

Joanna Hack^1*, Inês Ralha^1*, Sam Wilding, MSc, PhD^1*, Louise Stanton, MSc^2*, Josh Caddy, BSc^2*, Sharon Barrans, PhD^3*, Christoph Mamot, M.D.^4*, Urban Novak^5*, Cathy Burton, MBBChir, MA, MD, FRCPath^6*, Pamela McKay, MBChB, FRCP, FRCPath^7*, Gavin Campbell^8*, Andrew Davies^9* and Peter Johnson, MD, FRCP¹⁰

¹CRUK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
²Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
³Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁴Kantonsspital Aarau, Basel, CH, CHE
⁵Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
⁶Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds, United Kingdom
⁷Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁸Department of Haematology, Colchester General Hospital, Colchester, GBR
⁹Southampton Cancer Research UK (CRUK) Centre/CRUK Experimental Cancer Medicines Centre UK/CRUK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
¹⁰Cancer Research UK Centre, Southampton General Hospital, Southampton, United Kingdom

Juan Pablo Alderuccio, MD¹, Russ A Kuker, MD^2*, Isildinha M Reis, PhD^3*, Muthiah Nachiappan, MD^4*, Brad S. Kahl, MD⁵, Mehdi Hamadani, MD⁶, Weiyun Z. Ai, MD, PhD⁷, John Radford, MD, FRCPath, FMedSci^8*, Melhem Solh, MD⁹, Kirit M. Ardeshna¹⁰, Brian T. Hess, MD¹¹, Matthew A. Lunning, DO, FACP¹², Pier Luigi Zinzani, MD, PhD¹³, Anastasios Stathis, MD^14*, Carmelo Carlo-Stella, MD, PhD¹⁵, Eric Yu, PhD^16*, Paolo F Caimi, MD^17,18*, Deukwoo Kwon, PhD^19*, Izidore S. Lossos, MD²⁰, Fei Yang, PhD^21* and Craig H. Moskowitz, MD²²

¹Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
²Division of Nuclear Medicine, University of Miami Miller School of Medicine, Miami
³Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁴Division of Nuclear Medicine, Sylvester Comprehensive Cancer Center, Miami
⁵Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
⁶The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
⁷Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
⁸The Christie NHS Foundation Trust, Manchester Cancer Research Centre and Manchester Academic Health Science Centre, Manchester, United Kingdom
⁹BMT Group of Georgia, BMT Group of Georgia, Atlanta, GA
¹⁰Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
¹²Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
¹³IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
¹⁴Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, Switzerland
¹⁵Humanitas University and IRCCS Humanitas Research Hospital, Milan, Milano, Italy
¹⁶ADC Therapeutics America, Murray Hill, NJ
¹⁷Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
¹⁸Taussig Cancer Institute, Cleveland Clinic, Cleveland
¹⁹University of Miami, Miami, FL
²⁰Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
²¹Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, Miami
²²Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

Daniel J. Landsburg, MD¹, Jennifer J.D. Morrissette, PhD^2*, Stephen J. Schuster, MD¹, Sunita Dwivedy Nasta, MD³, James N. Gerson, MD¹, Stefan K. Barta, MD¹, Jakub Svoboda, MD¹, Elise A. Chong, MD⁴ and Megan S. Lim, MD, PhD²

¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
²Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴University of Pennsylvania, Philadelphia, PA

Paolo Strati, MD¹, Tae Min Kim, MD, PhD^2*, Alexey V Danilov, MD³, Chan Y. Cheah⁴, Dok Hyun Yoon, MD, PhD^5*, Wojciech Jurczak⁶, Shringi Sharma^7*, Jeong Lim Yoon^8*, Serena Arduini^9*, Jamal Saeh^8*, Richard F. Olsson^10* and Gareth Gregory^11*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Seoul National University Hospital, Seoul, Korea, Republic of (South)
³City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Linear Clinical Research, Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia
⁵Asan Medical Center, Seoul, Korea, Republic of (South)
⁶Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁷Oncology R&D, AstraZeneca, South San Francisco, CA
⁸Oncology R&D, AstraZeneca, Boston, MA
⁹Oncology R&D, AstraZeneca, Cambridge, United Kingdom
¹⁰Oncology R&D, AstraZeneca, Gothenburg, Sweden
¹¹Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia

Srichandhana Rajamouli, MD^1*, Eric McLaughlin, MS^2*, Walter Hanel, MD^3*, David A. Bond, MD, BS⁴, Yazeed Sawalha, MD⁵, Timothy J. Voorhees, MD, MSc⁶, Lapo Alinari, MD, PhD⁷, Lalit Sehgal, PhD⁸, Kami J. Maddocks, MD⁷, Beth Christian⁹, Daniel Jones, MD, PhD¹⁰ and Narendranath Epperla, MD, MS¹¹

¹Ohio State University, Columbus, OH
²Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, OH
³Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁴Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
⁵Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
⁶The Ohio State University James Comprehensive Cancer Center, Columbus, OH
⁷The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology, Columbus, OH
⁸Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
⁹The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
¹⁰The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹¹The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

Jakob D. Rudzki, MD^1*, Ulrich Jaeger, MD², Dominik Wolf, Univ. Prof., MD^3*, Andreas Petzer, Univ. Prof., MD^4,5, Richard Greil, MD⁶, Christina Peters, MD^7*, Hildegard T. Greinix, MD⁸, Andishe Attarbaschi, MD^9*, Veronika Buxhofer-Ausch, MD^4,5*, Michael Girschikofsky, MD^10*, Wolfgang Holter, MD^11*, Michael Leisch, MD^6*, Peter Neumeister, MD^8*, Peter Schlenke^12*, Clemens A. Schmitt, Univ. Prof., MD¹³, Wolfgang Schwinger, MD¹⁴, Nina Worel, MD^15* and Philipp Wohlfarth, MD^16*

¹Department for Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck, Innsbruck, Tyrol, Austria
²Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
³Department for Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria
⁴Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Linz, Austria
⁵Medical Faculty; Johannes Kepler University Linz, Linz, Austria
⁶Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
⁷Children’s Cancer Research Institute, 24509-58, Vienna, Austria
⁸Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
⁹Children’s Cancer Research Institute, St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria
¹⁰1st Medical Department, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
¹¹Children’s Cancer Research Institute, St. Anna Children's Hospital, Stem Cell Transplantation Unit, Medical University Vienna, Vienna, Austria
¹²Department for Blood Group Serology and Transfusion Medicine, Medical University Graz, Graz, Austria
¹³Department of Internal Medicine 3 – Hematology and Oncology, Kepler University Clinic, Johannes Kepler University, Linz, Austria
¹⁴Division of Pediatric Hematology and Oncology, Medical University Graz, Graz, Styria, Austria
¹⁵Transfusion Medicine, Medical University Vienna, Vienna, Vienna, Austria
¹⁶Division of Hematology, BMT-Unit, Medical University Vienna, Vienna, Austria

Bryan Valcarcel, MD^1*, Haruhiko Sano, MD^2*, Hiroo Katsuya, MD, PhD^3*, Atae Utsunomiya, MD⁴, Maki Otsuka, MD^5*, Masaharu Miyahara, MD^6*, Yasushi Takamatsu, MD, PhD^7*, Kenji Ishitsuka, MD, PhD⁸, Shinya Kimura, MD, PhD^2*, Junji Suzumiya, MD, PhD⁹, Kazuo Tamura, MD, PhD^7*, Daniel J Enriquez, MD¹⁰, Denisse Castro, MD¹¹, Brady E Beltran, MD^11*, Henry Idrobo, MD^12*, Camila Peña, MD¹³, Lorena Fiad, MD^14*, Juan Carlos Ramos, MD¹⁵ and Luis Enrique Malpica Castillo, MD¹⁶

¹Milken Institute School of Public Health, The George Washington University, Washington, MD
²Saga University, Saga, Japan
³Saga University, Saga, FKO, Japan
⁴Imamura General Hospital, Kagoshima, Japan
⁵National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
⁶Karatsu Red Cross Hospital, Karatsu, Japan
⁷Fukuoka University, Fukuoka, Japan
⁸Kagoshima University Hospital, Kagoshima, Japan
⁹Koga Community Hospital, Yaizu, Japan
¹⁰Departamento de Oncologia Medica, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
¹¹Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹²Hospital Universitario del Valle, Cali, Colombia
¹³Hematology Department, Hospital Del Salvador, Santiago, Chile
¹⁴Departamento de Hematologia, Hospital Italiano de La Plata, La Plata, Argentina
¹⁵Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
¹⁶Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Arushi Khurana, MBBS¹, Raphael Mwangi, MS^2*, Rebecca L. King, MD³, Thomas M. Habermann, MD⁴, Stephen M. Ansell, MD, PhD¹, James R. Cerhan, MD, PhD⁵, Grzegorz S. Nowakowski, MD¹, Thomas E. Witzig, MD⁴ and Matthew J. Maurer, DSc⁵

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
³Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁵Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Daniel A. Ermann, MD¹, Victoria A. Vardell, MD², Lindsey A. Fitzgerald, MD³, Harsh Shah, DO⁴, Boyu Hu, MD⁵ and Deborah M. Stephens, DO⁶

¹Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
²Department of Internal Medicine, University of Utah, Salt Lake City, UT
³Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁶Huntsman Cancer Institute, Salt Lake City, UT

Gabriel Roman Souza, MD¹, Katherine Thiel, MD^1*, Qianqian Liu, PhD^2*, Joel E Michalek, PhD^2* and Adolfo Enrique Diaz Duque, MD¹

¹University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
²Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX

Ariel Perez Perez, MD¹, Shreya Saxena, MD, MPH^2*, Tiba Al Sagheer, PharmD^3*, Muni Rubens, MD^4*, Talia Zahra, MD⁵, George Nahas, DO⁶, Alex V. Mejia Garcia, MD⁶, Lyle Feinstein, MD^6*, Lisa Reale, MD⁶, Marco Andres Ruiz, MD^6*, Peter L. Citron, MD^5*, Atulya Khosla, MD^5*, Manmeet Ahluwalia, MD^7*, Guenther Koehne, MD, PhD⁵ and Yuliya P.L. Linhares, MD⁵

¹Blood and Marrow Transplant Program, Miami Cancer Institute, Miami, FL
²Department of Clinical Research, Miami Cancer Institute, Baptist Health, Miami, FL
³Department of Pharmacy, Miami Cancer Institute, Baptist Health, Miami, FL
⁴Department of Biostatistics, Miami Cancer Institute, Baptist Health, Miami, FL
⁵Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami, FL
⁶Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami
⁷Neuro-Oncology, Miami Cancer Institute, Baptist Health, Miami, FL

Megan Melody, MD, MS¹, Frederique St. Pierre, MD^1*, Irene Helenowski, PhD^1*, William B Pearse, MD², Chetan V Vakkalagadda, MD^1*, Joseph R. Leventhal, MD, PhD^3*, John Friedewald, MD^3*, Bing Ho, MD, MPH^3*, Daniel Ganger, MD^4*, Jane N. Winter, MD¹, Leo I. Gordon, MD¹, Adam Yuh Lin, MD, PhD¹, Reem Karmali, MD, MSc¹, Shuo Ma, MD¹, Barbara Pro, MD⁵ and Jonathan Moreira, MD¹

¹Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
²Division of Hematology and Oncology, University of California, San Diego, La Jolla, CA
³Northwestern University Medical Center, Comprehensive Transplant Center, Chicago, IL
⁴Northwestern University Medical Center, Northwestern Medicine Digestive Health Center, Chicago, IL
⁵Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

Qian Wang^1*, Liqing Kang^2*, Yishan Duan^1*, Mao Jin^1*, Ying Zhu^1*, Mengya Cong^1*, Xin Xiang^1*, Xiao Ma^1*, Lei Yu^1*, Depei Wu³ and Haiwen Huang, MD^4*

¹The First Affiliated Hospital of Soochow University, Soochow, China
²Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, Soochow, China
³The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
⁴The department of hematology, the First Affiliated Hospital of Soochow University，National Clinical Research Center for Hematologic Diseases (Suzhou)，Jiangsu Institute of Hematology,, Suzhou, Jiangsu, China

Teresa Calimeri, MD, PhD^1*, Federico Erbella^2*, Lorella Orsucci, MD^3*, Teresa Aloisi, MD^4*, Annalisa Arcari, MD^5*, Cirino Botta, MD, PhD⁶, Annarosa Cuccaro, MD, PhD^7*, Pio Manlio Mirko Frascione, MD^8*, Stefania Girlanda, MD^9*, Manuel Gotti, MD^10*, Sabrina Mariani, MD^11*, Luca Nassi, MD^12*, Fioravante Ronconi, MD^13*, Luana Schiattone, MD^14*, Alessandra Tucci, MD^15*, Luisa Verga, MD^16*, Vincenzo Mercurio^17*, Paolo Fiore, MD^18*, Sara Steffanoni, MD^1*, Fabio Ciceri, MD^19* and Andrés José María J.M. Ferreri, MD²⁰

¹Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
²Hematology and Bone and Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
³Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Torino, Italy
⁴Department of Hematology, Ospedale Santa Chiara, Trento, ITA
⁵Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
⁶Department of Health Promotion, Mother and Child Care,Internal Medicine and Medical Specialties, University of Palermo, Italy, Palermo, Italy
⁷Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy
⁸Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
⁹Divisione di Oncologia,, Presidio ospedaliero Fatebenefratelli, ASST Fatebenefratelli-Sacco, Milan, Italy
¹⁰Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹¹U.O.C Ematologia, Dipartimento di Medicina Clinica e Molecolare,, A.O.U. Sant'Andrea, Sapienza Università di Roma, Roma, ITA
¹²Department of Hematology, AOU Careggi, Florence, Italy
¹³Division of Hematology, AORN Cardarelli, Napoli, ITA
¹⁴Dipartimento Oncologico-Ematologico, UOSD Centro Diagnosi e Terapia dei Linfomi, Pescara, Italy
¹⁵Department of Hematology, ASST Spedali Civili, Brescia, Italy
¹⁶Clinica Ematologica, Ospedale San Gerardo, ASST Monza, Università Milano Bicocca, Milano, Italy
¹⁷Clinical Research Unit, Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹⁸Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹⁹Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
²⁰Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

Nava Almog, PhD^1*, Anna Novokreshchenova, MS^1*, Sofia Smirnova, MS^1*, Jessica H. Brown, PhD^1*, Nikita Kotlov, MS^1*, Mark Meerson, MS^1*, Ilya Anosov^1*, Gorgun Akpek, MD², Keith Ayrons, MD^3*, Nathan H. Fowler, MD¹ and Kevin Ferguson, MD^4*

¹BostonGene, Corp, Waltham, MA
²Pacific Central Coast Health Centers at Dignity Health, Santa Maria
³Mission Hope Medical Oncology, Santa Maria
⁴WDSL Innovative Diagnostics, Santa Maria

Gustav Y Cederquist^1*, Kathryn R. Tringale, MD, MAS^1*, Carla Hajj, MD^1*, Harper Hubbeling, MD¹, Beatrice Fregonese, MPH^1*, Jisun Lee^1*, Michael Scordo, MD², Christian Grommes, MD³, Joachim Yahalom, MD¹ and Brandon S. Imber, MD¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
³Department of Medicine, Neuro-Oncology Service, Memorial Sloan Kettering Cancer, New York, NY

Akira Kawasaki, MD, PhD¹, Masaru Matsushita^1*, Shingo Yoshida^2*, Tanomu Matsukura^3*, Koji Izutsu, MD, PhD⁴ and Ryo Nishikawa, MD, PhD^5*

¹ONO Pharmaceutical, Osaka, Japan
²ONO Pharmaceutical, Osaka-Shi, Japan
³ONO Pharmaceutical, Tokyo, Japan
⁴Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁵Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan

Manju Sengar, MD, DM¹, Anu Korula, MD, DM^2*, Prasanth Ganesan, MD, DM^3*, Akhil Rajendra, MD^4*, Hasmukh Jain, MD, DM^5*, Prasanna Samuel, MSc, PhD^6*, Jayachandran P K, MD, DM^7*, Gaurav Prakash, MD, DM^8*, M. Joseph John, MD, DM⁹, Rasmi Palassery, MD^10*, Chandran K. Nair, MD, DNB, DM^11*, Tanuja Shet^12*, Sushil Selvarajan, MD, DM^13*, Lingaraj Nayak, MD, DM^5*, Parathan Karunakaran, MD, DM^14*, Fouzia NA, DNB, DM^2*, Om Prakash, MSc^6*, Bhausaheb Bagal, MD, DM^15*, Nikita Mehra, MD, DM^14*, Saranya Kumaran^16*, Sridhar Epari^17*, Jayshree Thorat, MD^18*, Venkatraman Radhakrishnan^14* and Aby Abraham, MD, DM^13*

¹Homibhaba National Institute, Mumbai, India, MUMBAI, India
²Department of Haematology, Christian Medical College, Vellore, India
³Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India
⁴Department of Medical Oncology, Tata Memorial Centre, Mumbai, Alabama, India
⁵Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
⁶Department of Biostatistics, Christian Medical College, Vellore, India
⁷Cancer Institute(WIA), Adyar, Chennai, India
⁸Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
⁹Department of Clinical Haematology and BMT, Christian Medical College & Hospital, Ludhiana, India
¹⁰Ramaiah Medical College and Hospital, Ramaiah Medical College and Hospital, Bengaluru, OH, India
¹¹Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, India
¹²Department of Pathology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
¹³Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India
¹⁴Department of Medical Oncology, Cancer Institute (WIA), Chennai, India
¹⁵Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
¹⁶CDMC, Christian Medical College, Vellore, Vellore, India
¹⁷Tata Memorial Hospital, Mumbai, India
¹⁸Adult Hematolymphoid Management Group, Tata Memorial Hospital,Mumbai, Mumbai, Maharashtra, India

Akinao Okamoto^1*, Masashi Sanada, MD, PhD², Takahiko Yasuda, MD, PhD^3*, Seiichi Kato, MD, PhD^4*, Akira Satou, MD, PhD^5*, Kosei Matsue, MD, PhD⁶, Hiroki Hosoi, MD, PhD^7*, Masahiro Yoshida, MD, PhD⁸, Satsuki Murakami, MD, PhD^9*, Eisei Kondo, MD, PhD^10*, Yasufumi Masaki, MD, PhD¹¹, Yasuhiro Suzuki, MD, PhD^12*, Kana Miyazaki, MD, PhD¹³, Tomohiro Kajiguchi, MD, PhD¹⁴, Junji Hiraga, MD, PhD^15*, Shingo Kurahashi^16*, Yuichiro Inagaki, MD, PhD^17*, Kazutaka Ozeki, MD, PhD¹⁸, Shigeki Saito, MD, PhD^19*, Toshiki Terao, MD^20*, Sachiko Iba^1*, Keiko Hattori^1*, Hideyuki Yamamoto, MD, PhD^1*, Naoe Goto, MD, PhD^1*, Chisako Iriyama, MD, PhD^1*, Masataka Okamoto, MD, PhD^1* and Akihiro Tomita, MD, PhD¹

¹Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan
²Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
³Clinical Research Center, Nagoya Medical Center, National Hospital Organization, Nagoya, Japan
⁴Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
⁵Department of Surgical Pathology, Aichi Medical University, Nagoya, AIC, JPN
⁶Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
⁷Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan
⁸Department of Hematology, Osaka City General Hospital, Osaka, Japan
⁹Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, AIC, Japan
¹⁰Kawasaki Medical School, Okayama, Japan
¹¹Department of Hematology and Immunology, Kanazawa Med. Univ., Kahoku-Gun, Ishikawa, Japan
¹²Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
¹³Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
¹⁴Department of Hematology and Oncology, Tosei General Hospital, Seto, Japan
¹⁵Department of Hematology, Toyota Memorial Hospital, Nagoya, JPN
¹⁶Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan
¹⁷Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
¹⁸Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, JPN
¹⁹18. Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
²⁰Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan

Andrew Ip, MD, MSc¹, Alex Mutebi, PhD^2*, Tongsheng Wang, MS^2*, Monika P. Jun, MPH^2*, Anupama Kalsekar, MS^2*, Fernando Rivas Navarro, MD, PhD, MBA^1*, Anthony Wang, PhD, MPH^3*, Rajesh Kamalakar, MS^3*, Mariana Sacchi, MD^2* and Brian Elliott, MD²

¹Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ
²Genmab, Princeton, NJ
³AbbVie, Inc., North Chicago, IL

Daniel Rosas, MD¹, Esteban Toro Velez, MD¹, Qianqian Liu, PhD^2,3*, Joel E Michalek, PhD^2* and Adolfo Enrique Diaz Duque, MD^4,5

¹Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
²Hematology-Oncology Division, UT Health San Antonio / Mays Cancer Center, San Antonio, TX
³Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
⁴University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
⁵Hematology-Oncology Division, Associate Professor, San Antonio, TX

Myrna Candelaria, MD, PharmD¹, Luis Villela, MD^2*, Marialejandra Alejandra Torres Viera, MD^3*, Camila Peña, MD⁴, Macarena Roa, MD^5*, Daniela Zambrano, MD^6*, Perla R. R. Colunga-Pedraza, MD⁷, Arianna Robles-Rodriguez, MD^8*, Fernando Pérez-Jacobo, MD⁹, Ana Carolina Oliver, MD¹⁰, María Victoria Irigoín, MD^11*, Rosio Baena, MD^12*, Henry Idrobo, MD^13,14*, Sally Rose Paredes, MD^15*, Rosa Oliday^16*, Denisse Castro, MD¹⁷, Efreen Montaño Figueroa, MD, PhD^18*, Guilherme Fleury Perini, MD^19*, Luis Enrique Malpica Castillo, MD^20,21, Brady E Beltran, MD^17* and Jorge J. Castillo, MD²²

¹Research Division, Instituto Nacional de Cancerología, Mexico, Mexico
²Escuela De Medicina Del Tecnologico De Monterrey, Centro Medico Zambrano Hellion, Hermosillo, NL, Mexico
³Hematology Department, Clinica Santa Sofía, caracas, Venezuela (Bolivarian Republic of)
⁴Hematology Department, Hospital Del Salvador, Santiago, Chile
⁵Hospital Del Salvador, Santiago, Chile
⁶Hematology Service, Hospital del Salvador, Santiago, Chile
⁷Servicio De Hematología, Hospital Universitario, Monterrey, Mexico
⁸hematology department, Univerisidad de Guadalajara/ Hospital general de occidente, Zapopan, Mexico
⁹Hematology Department, Hospital Central Norte Petróleos Mexicanos, Ciudad DE Mexico, Mexico
¹⁰Hematology Department, Hospital Britanico, CASMU, Montevideo, Uruguay
¹¹Hospital Británico CASMU, montevideo, Uruguay
¹²Instituto Oncológico Nacional Caja Petrolera de Salud, Cochabamba, Bolivia
¹³Facultad de Medicina., Universidad Del Valle, Cali, Colombia
¹⁴Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia
¹⁵Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, LIMA, Peru
¹⁶Sociedad Científica de Hematología de Cuba, Cuba, Cuba
¹⁷Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹⁸Hematology Department, Hospital General de Mexico, MExico city, Mexico
¹⁹Hospital Israelita Albert Einstein, Sao Paulo, PA, Brazil
²⁰University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²²Dana Farber Cancer Institute, Boston, MA

Luis Alberto de Padua Covas Lage, MD, PhD^1,2,3*, Vinícius Araújo Soares, MD^4*, Thales Dalessandro Meneguin, MD^4*, Hebert Fabricio Culler, MSc, PhD^5,6*, Cadiele Oliana Reichert, MSc^7*, Mayara D’Auria Jacomassi, MSc^8*, Diego Gomes Cândido Reis^9,10, Maria Cláudia Nogueira Zerbini, MD, PhD^11*, Renata Oliveira Costa, MD, PhD¹², Vanderson Rocha, MD, PhD^13,14,15* and Juliana Pereira, MD, PhD^10,16

¹Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
²Medical Research Laboratory on Molecular Hematology (LIM-31), Universidade de São Paulo, São Paulo, Brazil
³Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
⁴Department of Hematology, Hemotherapy and Cell Therapy, University of São Paulo, São Paulo, Brazil
⁵Department of Hematology, Hemotherapy and Cell Therapy, Universidade de São Paulo (USP), Sao Paulo, Brazil
⁶Medical Laboratory Investigation 31 - LIM31, Universidade de São Paulo (USP), Sao Paulo, Brazil
⁷Medical Laboratory Investigation 19 - LIM19, Universidade de São Paulo (USP), Sao Paulo, Brazil
⁸University of Sao Paulo, Sao Paulo, Brazil
⁹Department of Hematology- Hospital das Clínicas da Faculdade de Medicina da USP- HCFMUSP, Universidade de São Paulo, SAO PAULO, AC, Brazil
¹⁰Department of Hematology- Hospital das Clínicas da Faculdade de Medicina da USP- HCFMUSP, Universidade de São Paulo, São Paulo, Brazil
¹¹Pathology department, Universidade de São Paulo, Sao Paulo, Brazil
¹²Department of Hematology and Hemotherapy, Centro Universitário Lusíadas, Santos, Brazil
¹³Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clinicas, Faculty of Medicine, Sao Paulo University (FM-USP), Sao Paulo, Brazil
¹⁴Institut de Recherche de Saint-Louis (IRSL) EA3518, Eurocord, Saint Louis Hospital, APHP, Université de Paris, Paris, France
¹⁵Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
¹⁶Serviço de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SAO PAULO, Brazil

Nikita Dave^1*, Jennifer J.D. Morrissette, PhD^2*, Stephen J. Schuster, MD¹, Sunita Dwivedy Nasta, MD³, James N. Gerson, MD¹, Stefan K. Barta, MD¹, Jakub Svoboda, MD¹, Elise A. Chong, MD⁴, Megan S. Lim, MD, PhD² and Daniel J. Landsburg, MD¹

¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
²Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴University of Pennsylvania, Philadelphia, PA

Burhan Ferhanoglu, MD¹, Zafer Gulbas^2*, Ant Uzay^3*, Muhit Özcan, MD^4*, Fahir Ozkalemkas, MD^5*, Mehmet Sinan Dal, MD^6*, Hakan Kalyon^7*, Olga Meltem Akay^7*, Burak Deveci, MD^8*, Huseyin Bekoz^9*, Omur Gokmen Sevindik^9*, Tayfur Toptas, MD^10*, Asu Fergun Yilmaz, MD^10*, Derya Koyun^11*, Nihan Alkis^2* and Elif Birtas Atesoglu^7*

¹Hematology Department, Koç University, School of Medicine, Istanbul, Turkey
²Anadolu Medical Center, Gebze, Turkey
³Hematology, Acibadem Atakent Hospital, Istanbul, Turkey
⁴Ankara University School of Medicine Department of Hematology, Ankara, Turkey
⁵Hematology, Uludag University Faculty of Medicine, Bursa, Turkey
⁶Ankara Oncology Hospital, Ankara, Turkey
⁷Department of Internal Medicine, Division of Hematology, Koç University School of Medicine, Istanbul, Turkey
⁸Medstar Hospital, Antalya, Turkey
⁹Hematology, Medipol University Hospital, Istanbul, Turkey
¹⁰Hematology, Marmara University Hospital, Istanbul, Turkey
¹¹Ankara University School of Medicine Department of Hematology, ANKARA, Turkey

Ahmed Ludvigsen Al-Mashhadi^1*, Lasse Hjort Jakobsen, MSc, PhD^1*, Peter de Nully Brown, MD, PhD^2*, Anne Ortved Gang, MD, PhD^2*, Anne-Luise Thorsteinsson^2*, Kaziwa Rasoul^2*, Judith Melchior Heissmann^3*, Michael Buch Tøstesen^4*, Mette Nieman Christoffersen^5*, Jelena Jelicic^6*, Jennifer Bøgh Jørgensen^7*, Troels Thomsen^7*, Andriette Dessau-Arp, MD^8*, Andreas PH Andersen^9*, Mikael Frederiksen, MD^9*, Per Troellund Pedersen^8*, Michael Roost Clausen, MD, PhD^6*, Judit Jørgensen^4*, Christian Bjørn Poulsen, MD^3*, Tarec Christoffer Christoffer El-Galaly, MD, DSc¹ and Thomas S. Larsen, MD, PhD^5*

¹Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
²Department of Haematology, Rigshospitalet, Copenhagen, Denmark
³Department of Haematology, Zealand University Hospital, Roskilde, Denmark
⁴Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
⁵Department of Haematology, Odense University Hospital, Odense, Denmark
⁶Department of Haematology, Vejle Hospital, Vejle, Denmark
⁷Department of Internal Medicine, Haematology section, Gødstrup Hospital, Herning, Denmark
⁸Department of Haematology, South West Jutland Hospital, Esbjerg, Denmark
⁹Department of Hematology, Hospital of Southern Jutland, Aabenraa, Denmark

Luis Mario Villela Martinez, MD, MSc^1,2*, Brady E. Beltrán, MD^3,4*, Marialejandra Alejandra Torres Viera, MD^5*, Henry Idrobo, MD, Professor^6,7*, Myrna Candelaria, MD, PharmD^8,9, Guilherme Fleury Perini, MD^10*, Ana Carolina Oliver, MD^11,12, Denisse Castro, MD^3,4, Rosa Oliday^13*, Sally Rose Paredes, MD^3,14*, Ana Florencia Ramirez-Ibarguen, MD^15*, Lidiane Andino^16*, Silvia Rivas-Vera, MD¹⁷, Seisha Alana Von Glasenapp Gossen^18*, Victoria Irigoin, MD^19*, Gladys P Agreda, MD, PhD^20*, Fernando Perez-Jacobo, MD^21*, Perla R. R. Colunga-Pedraza, MD²², Efreen Montaño Figueroa, MD, PhD^23*, Lorena Fiad, MD^24*, Fabiola Valvert, MD²⁵, Camila Peña, MD²⁶, Jose A Hernández-Hernández, PhD^27*, Virginia Otero, MD^28*, Melani Otañez, MD^29*, Guillermo J. Ruiz-Arguelles, FRCP³⁰, Arianna Robles, MD^31*, Carlos Best, MD^32*, David Gomez-Almaguer, MD³³, Rosio Baena, MD^34*, Saul Urquijo, MD^35*, Eleazar Hernandez, MD^36*, Jose Luis Álvarez^37*, Melissa Castro, MD^38*, Jorge J. Castillo, MD^39,40 and Luis Enrique Malpica Castillo, MD^41,42

¹Escuela de Medicina Del Tecnológico de Monterrey, Hermosillo, SO, Mexico
²Servicio de hematología, Centro Medico Dr. Ignacio Chavez del ISSSTESON, Hermosillo, SO, Mexico
³Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
⁴Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
⁵Srvicio de hematologia, Universidad de Caracas, Caracas, Venezuela (Bolivarian Republic of)
⁶RENEHOC, Bogotá, Colombia
⁷Universidad del Valle, Hospital Universitario Del Valle Evaristo García E.S.E, Cali, Colombia
⁸Research Division, Instituto Nacional de Cancerología, Mexico, Mexico
⁹Research Division: Instituto Nacional de Cancerología, Mexico City, Mexico
¹⁰Hospital Israelita Albert Einstein, Sao Paulo, PA, Brazil
¹¹Hematology Department, British Hospital, Montevideo, Uruguay
¹²Hematology Department, Hospital Britanico, CASMU, Montevideo, Uruguay
¹³Sociedad Científica de Hematología de Cuba, Cuba, Cuba
¹⁴Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, LIMA, Peru
¹⁵Instituto Nacional de Cancerologia, Mexico, Mexico
¹⁶Hematology Service, Hospital Central del Instituto de Previsión Social, Asuncion, Paraguay
¹⁷Hematology Department, INCAN, Benito Juarez, Mexico
¹⁸Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
¹⁹HEmatology Department, Hospital Britanico CASMU, montevideo, Uruguay
²⁰Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
²¹Hematology and blood bank services, Hospital Central Norte PEMEX, CDMX, Mexico
²²Servicio De Hematología, Hospital Universitario, Monterrey, Mexico
²³Hospital General de Mexico, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, DF, Mexico
²⁴Departamento de Hematologia, Hospital Italiano de La Plata, La Plata, Argentina
²⁵Instituto De Cancerología y Hospital Dr. Bernardo Del Valle (INCAN), Ciudad de Guatemala, Guatemala
²⁶Hematology Department, Hospital Del Salvador, Santiago, Chile
²⁷Tecnológico de Monterrey, Escuela de Medicina. TecSalud, Monterrey, NL, Mexico
²⁸Hematology Service, Hospital Italiano, Buenos Aires, Argentina
²⁹Hospital General del Estado de Sonora, Hermosillo, SO, Mexico
³⁰Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico
³¹Universidad de Guadalajara, CUCS, HGO, Zapopan, MEX
³²Hematologia, Universidad de Guadalajara, Hospital General de Occidente, Zapopan, Mexico
³³Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
³⁴Instituto Oncológico Nacional Caja Petrolera de Salud, Cochabamba, Bolivia
³⁵Hospital Fernando Ocaranza del ISSSTE, Universidad Autonoma de Sinaloa. Facultad de Medicina, Hermosillo, SO, Mexico
³⁶Centro Medico 20 de Noviembre del ISSSTE, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, DF, Mexico
³⁷Centro Medico 20 de noviembre del ISSSTE, UNAM, Ciudad de Mexico, DF, Mexico
³⁸Hospital Fernando Ocaranza del ISSSTE, Universidad Autonoma de Sinaloa, Hermosillo, SO, Mexico
³⁹Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
⁴⁰Dana Farber Cancer Institute, Boston, MA
⁴¹University of Texas MD Anderson Cancer Center, Houston, TX
⁴²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Jinchul Kim^1*, Jinhyun Cho, MD^2*, Won Seog Kim, MD, PhD^3* and Seok Jin Kim, MD, PhD³

¹Department of Hematology-Oncology, Inha University College of Medicine and Hospital, Incheon, South Korea
²Department of Hematology-Oncology, Inha University College of Medicine and Hospital, Incheon, Korea, Republic of (South)
³Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Shinpei Harada^1*, Hideki Goto, M.D., Ph.D.^2*, Hajime Senjo, M.D.², Keito Suto, M.D.^2*, Shiro Watanabe, M.D., Ph.D.^3*, Yuko Uchiyama, M.D., Ph.D.^3*, Koh Izumiyama^4*, Masayo Yamamoto, M.D., Ph.D.^5*, Kazuya Sato, M.D., Ph.D.⁶, Yasutaka Kakinoki, M.D., Ph.D.^7*, Tomoyuki Saga, M.D.^8*, Akio Shigematsu, M.D., Ph.D.⁹, Hiroto Horiguchi, MD, PhD¹⁰, Mutsumi Takahata, M.D., Ph.D.^11*, Reiki Ogasawara, M.D., Ph.D.^12*, Satoshi Yamamoto, M.D., Ph.D.^13*, Keisuke Yamaguchi, M.D., Ph.D.^14*, Kentaro Wakasa, M.D., Ph.D.^15*, Tetsuyuki Igarashi, M.D.^16*, Yoshihito Haseyama, M.D, Ph.D.^17*, Shinichi Ito, M.D.^18*, Katsuya Fujimoto, M.D., Ph.D.^19*, Junichi Hashiguchi, M.D., Ph.D.^20*, Masao Nakagawa, M.D., Ph.D.² and Takanori Teshima, M.D., Ph.D.²

¹Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo City, Japan
²Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
³Department of Nuclear Medicine, Hokkaido University Hospital, Sapporo, Japan
⁴Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
⁵Division of Metabolism and Biosystemic Science, Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan
⁶Department of Hematology/Oncology, Asahikawa Kosei General Hospital, Asahikawa, Japan
⁷Department of Hematology, Asahikawa City Hospital, Asahikawa, HOK, Japan
⁸Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan
⁹Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
¹⁰Department of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
¹¹Department of hematology, Sapporo-Kosei General Hospital, Sapporo, Japan
¹²Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
¹³Department of Hematology, Sapporo City General Hospital, Sapporo, Japan
¹⁴Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan
¹⁵Division of Hematology, Hokkaido P.W.F.A.C. Obihiro-Kosei General Hospital, Obihiro, Japan
¹⁶Department of Hematology, Tenshi Hospital, Sapporo, HOK, Japan
¹⁷Department of Hematology, Tonan Hospital, Sapporo, Japan
¹⁸Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan
¹⁹Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
²⁰Department of Hematology, Kitami Red Cross Hospital, Kitami, Japan

Reid M. Muenzen^1*, Mitchell E. Hughes, PharmD^2*, Sunita Dwivedy Nasta, MD², Jakub Svoboda, MD², Daniel J. Landsburg, MD², Stefan K. Barta, MD², Donald Tsai, MD, PhD³, Stephen J. Schuster, MD² and Elise A. Chong, MD²

¹Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
²Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Caixia Li^1*, Jia Wei^2*, Keshu Zhou^3*, Peng Liu, MD⁴, He Huang⁵, Fei Li^6*, Yujun Dong^7*, Qingqing Cai, PhD⁸, Shenmiao Yang^9*, Xinyou Zhang^10*, Hui Zhou^11*, Lu Zhang^12*, Zaixing Shi^12*, Zhiyu Liang^12*, Binghao Wu^12* and Depei Wu¹

¹The First Affiliated Hospital of Soochow University, Jiangsu, China
²Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, China
³HeNan Cancer Hospital, Zhenghzhou, China
⁴Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
⁵Zhejiang University – The First Affiliated Hospital, Hangzhou, China
⁶The First Affiliated Hospital of Nanchang University, Nanchang, China
⁷Department of Hematology, Peking University First Hospital, Beijing, China
⁸Sun Yat-Sen University Cancer Center, Guangzhou, China
⁹Peking University People’s Hospital, Beijing, China
¹⁰Shenzhen People’s Hospital, Shenzhen, China
¹¹Hunan Cancer Hospital, Changsha, China
¹²BeiGene (Shanghai) Co., Ltd., Shanghai, China

Ho-Young Yhim, MD, PhD¹, Yong Park, MD, PhD², Jeong-A Kim³, Ho-Jin Shin^4*, Young Rok Do, MD, PhD⁵, Joon Ho Moon, MD^6*, Min Kyoung Kim, MD, PhD^7*, Won Sik Lee, MD, PhD⁸, Dae Sik Kim, MD^9*, Myung-Won Lee, M.D., Ph.D.^10*, Yoon Seok Choi, MD, PhD¹¹, Seong Hyun Jeong, MD^12*, Kyoung Ha Kim, MD, PhD^13*, Chang-Hoon Lee, MD, PhD^14*, Ga-Young Song, MD^15*, Jae-Yong Kwak, MD, PhD¹⁶ and Deok-Hwan Yang, MD, PhD^17*

¹Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea, Republic of (South)
²Department of Internal Medicine, Korea University College of Medicine, Anam Hospital, Seoul, Korea, Republic of (South)
³Department of Hematology, St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
⁴Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
⁵Department of Internal Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
⁶Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea, Republic of (South)
⁷Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea, Republic of (South)
⁸Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
⁹Department of Internal Medicine, Korea University College of Medicine, Guro Hospital, Seoul, Korea, Republic of (South)
¹⁰Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea, Republic of (South)
¹¹Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
¹²Department of Hematology-Oncology,, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
¹³Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea, Republic of (South)
¹⁴Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Chonbuk, Korea, Republic of (South)
¹⁵Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
¹⁶Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea, Republic of (South)
¹⁷Department of Internal Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)

Reham Abdelaziz Khedr, MD^1,2, Ebtihal Mahmoud Abdelaziz^3*, Nashwa Ezzaldin^4* and Hadir Almahallawy, PhD^5*

¹Pediatric oncology, Chlidren’s Cancer Hospital Egypt 57357, Cairo, Egypt
²Pediatric oncology, National Cancer Institute - Cairo university, Cairo, Egypt
³Pediatric Oncology, National Cancer Institute - Cairo University, Cairo, Egypt
⁴Pediatric Oncology, NAtional Cancer Institute - Cairo University, Cairo, Egypt
⁵National Cancer Institute - Cairo University, cairo, Egypt